Showing results (331-340 of 1,369) with videos related to
Sort By:
Pageof 137
Nature Reviews. Cancer|September 25, 2008
The TRAIL apoptotic pathway in cancer onset, progression and therapyRicky W Johnstone, Ailsa J Frew, Mark J SmythNature Reviews. Immunology|July 31, 2020
Targeting CD39 in cancerAchim K Moesta, Xian-Yang Li, Mark J SmythClinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 29, 2013
Targeting CD73 enhances the antitumor activity of anti-PD-1 and anti-CTLA-4 mAbsBertrand Allard, Sandra Pommey, Mark J Smyth, et al.Immunity|July 30, 2013
Mechanism of action of conventional and targeted anticancer therapies: reinstating immunosurveillanceLaurence Zitvogel, Lorenzo Galluzzi, Mark J Smyth, et al.European Journal of Immunology|February 13, 2001
Granzyme A and B-deficient killer lymphocytes are defective in eliciting DNA fragmentation but retain potent in vivo anti-tumor capacityJ E Davis, M J Smyth, J A TrapaniCurrent Opinion in Immunology|June 21, 2005
Working with NKT cells--pitfalls and practicalitiesStuart P Berzins, Mark J Smyth, Dale I GodfreyJournal of Immunology (Baltimore, Md. : 1950)|November 15, 1986
Potentiation of the in vitro cytotoxicity of chlorambucil by monoclonal antibodiesM J Smyth, G A Pietersz, I F McKenzieJournal of the National Cancer Institute|December 1, 1987
Use of vasoactive agents to increase tumor perfusion and the antitumor efficacy of drug-monoclonal antibody conjugatesM J Smyth, G A Pietersz, I F McKenzieCancer Research|February 15, 1988
Immunochemotherapy of a murine thymoma with the use of idarubicin monoclonal antibody conjugatesG A Pietersz, M J Smyth, I F McKenzieThe American Review of Respiratory Disease|December 1, 1986
Thoracoabdominal motion in response to treadmill and cycle exerciseJ A Wells, R J Smyth, A S RebuckPageof 137